Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia

Clinical trial NCT00229619 · COMPLETED

Trial details

NCT number: NCT00229619
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anemia, Aplastic Red-Cell Aplasia, Pure Anemia, Diamond-Blackfan

Start date: 2005-09-01
Primary completion: 2010-06-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.